Literature DB >> 788743

Blood pressure responses to noradrenaline and dopamine infusions in Parkinson's disease and the Shy-Drager syndrome.

C S Wilcox, M J Aminoff.   

Abstract

Studies of pulse rate and blood pressure responses to graded intravenous infusions of noradrenaline and dopamine were performed on five patients with Parkinson's disease, five with the Shy-Drager syndrome and seven healthy subject. Cardiovascular reflex responses to standing and to the Valsalva manoeuvre were found to be preserved in all patients with Parkinson's disease but to be grossly defective or absent in all with the Shy-Drager syndrome. Each subject received separate intravenous infusions of L-noradrenaline and dopamine, delivered at increasing rates, until a 30% rise in systolic blood pressure was achieved. Heart rate decreased during pressor responses to noradrenaline in control subjects and patients with Parkinson's disease, but increased in those with the Shy-Drager syndrome. Heart rate increased during pressor responses to dopamine in all subjects. Compared to control subjects supersensitivity to noradrenaline was observed both in patients with Parkinson's disease and, to a greater extent, in those with the Shy-Drager syndrome. Subsensitivity to dopamine was observed in patients with Parkinson's disease, but supersensitivity in those with the Shy-Drager syndrome.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 788743      PMCID: PMC1428863          DOI: 10.1111/j.1365-2125.1976.tb00594.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  17 in total

1.  Supersensitivity and subsensitivity to sympathomimetic amines.

Authors:  U TRENDELENBURG
Journal:  Pharmacol Rev       Date:  1963-06       Impact factor: 25.468

2.  Effects of Dopamine in man.

Authors:  D HORWITZ; 3 D FOX SM; L I GOLDBERG
Journal:  Circ Res       Date:  1962-02       Impact factor: 17.367

3.  Pilomotor and sudomotor innervation in diabetes.

Authors:  F R BARANY; E H COOPER
Journal:  Clin Sci       Date:  1956-11       Impact factor: 6.124

4.  Proceedings: Enhanced pressor response to noradrenaline in human subjects with chronic sympathetic decentralization.

Authors:  N J Christensen; H L Frankel; C J Mathias; J M Spalding
Journal:  J Physiol       Date:  1975-11       Impact factor: 5.182

5.  Action of some sympathomimetic amines on the cat's iris, in situ or isolated.

Authors:  E MARLEY
Journal:  J Physiol       Date:  1962-07       Impact factor: 5.182

6.  The response of the sweat glands to some locally acting agents in human subjects.

Authors:  H D JANOWITZ; M I GROSSMAN
Journal:  J Invest Dermatol       Date:  1950-06       Impact factor: 8.551

Review 7.  Cardiovascular and renal actions of dopamine: potential clinical applications.

Authors:  L I Goldberg
Journal:  Pharmacol Rev       Date:  1972-03       Impact factor: 25.468

8.  Evidence for a centrally mediated hypotensive effect of L-dopa in the rat.

Authors:  M Henning; A Rubenson
Journal:  J Pharm Pharmacol       Date:  1970-03       Impact factor: 3.765

9.  Levodopa therapy for Parkinsonism in the Shy-Drager syndrome.

Authors:  M J Aminoff; C S Wilcox; M M Woakes; M Kremer
Journal:  J Neurol Neurosurg Psychiatry       Date:  1973-06       Impact factor: 10.154

Review 10.  Dopamine (3-hydroxytyramine) and brain function.

Authors:  O Hornykiewicz
Journal:  Pharmacol Rev       Date:  1966-06       Impact factor: 25.468

View more
  4 in total

1.  Risk Factors for Cardiac Complications in Patients With Pheochromocytoma and Paraganglioma: A Retrospective Single-Center Study.

Authors:  Lin Zhao; Xu Meng; QiMin Mei; Hua Fan; YeCheng Liu; XianLiang Zhou; HuaDong Zhu; ShuYang Zhang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-01       Impact factor: 6.055

2.  The pressor actions of noradrenaline, angiotensin II and saralasin in chronic autonomic failure treated with fludrocortisone.

Authors:  B Davies; R Bannester; P Sever; C Wilcox
Journal:  Br J Clin Pharmacol       Date:  1979-09       Impact factor: 4.335

3.  The pressor actions of noradrenaline and angiotension II in chronic autonomic failure treated with indomethacin.

Authors:  I B Davies; R Bannister; C Hensby; P S Sever
Journal:  Br J Clin Pharmacol       Date:  1980-09       Impact factor: 4.335

4.  Systemic postganglionic adrenergic studies do not distinguish Parkinson's disease from multiple system atrophy.

Authors:  Axel Lipp; Paola Sandroni; Phillip A Low
Journal:  J Neurol Sci       Date:  2009-04-05       Impact factor: 3.181

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.